Health Care & Life Sciences » Pharmaceuticals | Kyowa Hakko Kirin Co. Ltd.

Kyowa Hakko Kirin Co. Ltd.

Kyowa Hakko Kirin Co. Ltd.
Stock Exchange Other OTC
EPS
$0.67
Market Cap
$9.53 B
Shares Outstanding
576.48 M
Public Float
-
Kyowa Hakko Kirin Co. Ltd.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
576.48 M
Public Float
-
Kyowa Hakko Kirin Co. Ltd.
Stock Exchange Tokyo Stock Exchange
EPS
JPY74.09
Market Cap
JPY1.03 T
Shares Outstanding
540 M
Public Float
227.24 M

Profile

Address
Otemachi Financial City Grand Cube
Tokyo Tokyo 100
Japan
Employees -
Website http://www.kyowa-kirin.co.jp
Updated 07/08/2019
Kyowa Hakko Kirin Co., Ltd. engages in the manufacture and sale of medical and pharmaceutical products. It operates through the Pharmaceuticals and Bio-Chemicals segments. The Pharmaceuticals segment deals with the research, development, production, and sale of in vitro diagnostic reagents and ethical drugs concerning renal anemia, leukemia, cancer, allergies, and hypertension.

Financials

View All
Created with Highcharts 5.0.14Kyowa Hakko Kirin Co. Ltd.Net Income. Fiscal year is January-December. All values JPY Millions.30 07830 07815 89815 89829 77429 77430 45030 45042 89942 89954 41454 414201320142015201620172018010k20k30k40k50k60k
Created with Highcharts 5.0.14Kyowa Hakko Kirin Co. Ltd.Sales/Revenue. Fiscal year is January-December. All values JPY Millions.340 611340 611333 446333 446364 316364 316347 956347 956353 380353 380346 531346 5312013201420152016201720180100k200k300k400k

Nobuo Hanai
Chairman & Chief Executive Officer
Masashi Miyamoto
President, COO & Representative Director